Eδω θα σας εχω να σας γλενταω πελατες μου.
The first HPV vaccine, Gardasil, was approved by the US Food and Drug Administration (FDA) in 2006. Two years later, India approved that drug, which is made by Merck, based in Whitehouse Station, New Jersey, as well as Cervarix, another HPV vaccine, made by GlaxoSmithKline, based in London. Both vaccines had been approved for use by the US Food and Drug Administration before the PATH project began in 2009. The study, which used donations of these vaccines and was funded by the Bill and Melinda Gates Foundation, aimed to gather evidence as to how an HPV vaccine might best be widely introduced within the Indian health-care system.
It involved vaccinating 13,000 girls aged 10–14 in the state of Andhra Pradesh with Gardasil and 10,000 with Cervarix in Gujarat, and analysed, for example, how to raise community awareness of HPV, and whether delivering vaccines was best achieved at schools or in health centres.
The study was initially intended to run until 2011, but the Indian government halted the trials in March 2010 after activist groups opposed to the introduction of the vaccine in India alleged safety and ethical violations following the death of seven girls enrolled in the study. https://www.nature.com/articles/nature.2013.13700.
Αναφερόμενος στη χαλάρωση της καραντίνας, ο Σόιμπλε δήλωσε ότι "δεν μπορούμε να εμπιστευθούμε την απόφαση αποκλειστικά στους επιδημιολόγους, αλλά πρέπει να σταθμίσουμε και τις σημαντικές οικονομικές, κοινωνικές, ψυχολογικές ή άλλες επιπτώσεις".
.
